And Oncology x2 sale by the end of this year and early next and Merck milestone payment (potentially) early next year for BNC375 moving into Phase 2 trial. (another 20 to 30mil)
- Forums
- ASX - By Stock
- BNO
- BP still has it at $0.69 with BNC210 license intact
BP still has it at $0.69 with BNC210 license intact, page-7
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)